NCT02300012

Brief Summary

Incident rates of ACL rupture are greatest in 16-39 year olds at almost 1 in 1,000. Performance Based Investigations (PBIs) can be used to evaluate and select correct approaches to patient treatment, and biochemical, biomechanical and physiological biomarkers in other conditions are sensitive in distinguishing between disease state severities, type of injuries and responsiveness to treatment. Despite the measurement sensitivity of PBIs, these are not widely used possibly owing to their focus postoperatively where benefits are less worthwhile. This study aims to investigate novel biomarkers as performance based investigations (PBIs) to improve surgical and treatment strategies in anterior cruciate ligament (ACL) patients. The objectives are to identify whether biomarkers, collected before and after operations, can: 1) Assist the surgeon in decision making; 2) Lead to improved prognosis; 3) Be used to predict the outcomes of prognosis, and; 4) Correlate with disease signs/ smoking to help further understand ACL injuries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 24, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

January 5, 2015

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2022

Completed
Last Updated

May 27, 2022

Status Verified

May 1, 2022

Enrollment Period

7.4 years

First QC Date

October 23, 2014

Last Update Submit

May 23, 2022

Conditions

Keywords

Anterior cruciate ligamentPerformance based investigations

Outcome Measures

Primary Outcomes (8)

  • The change in knee varus/valgus from baseline to 6 weeks post-ACL reconstruction, measured when performing a single leg squat.

    Baseline, 6 weeks

  • The change in knee varus/valgus from baseline to 6 months post-ACL reconstruction, measured when performing a single leg squat

    Baseline, 6 months

  • The change in peak vertical ground reaction force from baseline to 6 weeks post-ACL reconstruction, measured when performing a novel isometric task during sitting.

    Baseline, 6 weeks

  • The change in peak vertical ground reaction force from baseline to 6 months post-ACL reconstruction, measured when performing a novel isometric task during sitting.

    Baseline, 6 months

  • The change in anterior-posterior centre of pressure displacement from baseline to 6 weeks post-ACL reconstruction, measured when performing a 10 second standing balance task.

    Baseline, 6 weeks

  • The change in anterior-posterior centre of pressure displacement from baseline to 6 months post-ACL reconstruction, measured when performing a 10 second standing balance task.

    Baseline, 6 months

  • The change in time taken to complete a sit-to-stand task, from baseline to 6 weeks post-ACL reconstruction

    Baseline, 6 weeks

  • The change in time taken to complete a sit-to-stand task, from baseline to 6 months post-ACL reconstruction

    Baseline, 6 months

Secondary Outcomes (5)

  • The change in Interleukin-6 obtained from blood samples at baseline to 6 months post-ACL reconstruction

    6 months post-ACL reconstruction

  • The change in Tegner Activity Score from baseline to 6 months post-ACL reconstruction

    6 months post-ACL reconstruction

  • The change in Lysholm Knee Scoring Scale from baseline to 6 months post-ACL reconstruction

    6 months post-ACL reconstruction

  • The change in International Knee Documentation Committee subjective knee evaluation form from baseline to 6 months post-ACL reconstruction

    baseline to 6 months post-ACL reconstruction

  • The difference in bone morphogenetic protein-7 (BMP-7) between smokers and non-smokers who undergo ACL reconstruction

    At time of surgery

Study Arms (4)

Operation - No PBI

NO INTERVENTION

Patients requiring operation - baseline PBI data not seen by surgeon

Operation - PBI available

EXPERIMENTAL

Patients requiring operation - baseline PBI data seen by surgeon pre-operatively

Procedure: Surgeons knowledge of pre-operative PBIs

Non-operation

NO INTERVENTION

Patients with ACL rupture not requiring operation

Control

NO INTERVENTION

Healthy age matched volunteers - No operation

Interventions

Surgeon performing ACL repair will have prior knowledge of patients pre-operative PBIs to inform surgical practice

Operation - PBI available

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • unilateral ACL rupture
  • years old

You may not qualify if:

  • combined posterior and ACL rupture
  • multi-ligament instability including medial or lateral collateral ligament injury
  • other lower limb surgery \<3mths
  • current significant acute injury affecting other lower extremity joints, or other relevant neurological or musculoskeletal pathology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

United Lincolnshire Hospitals NHS Trust

Lincoln, Lincolnshire, LN2 5QY, United Kingdom

Location

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Officials

  • Prof David Mullineaux, PhD

    University of Lincoln

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2014

First Posted

November 24, 2014

Study Start

January 5, 2015

Primary Completion

May 20, 2022

Study Completion

May 20, 2022

Last Updated

May 27, 2022

Record last verified: 2022-05

Locations